Actavis launches Terbinafine hydrochloride tablets in the U.S.

Editorial Checklist Reviewed
Jul 10 2007NewsGuard 100/100 Score

Actavis Group has announced that it has launched Terbinafine hydrochloride tablets in the U.S. Distribution of the product will commence immediately.

Terbinafine hydrochloride tablets, the generic equivalent of Novartis' Lamisil(R) tablets, will be available in 250 mg strength. Terbinafine hydrochloride tablets are indicated for the treatment of fungal infections of the fingernail and toenail.

Annual sales of terbinafine hydrochloride tablets in the U.S. were approximately US$687 million for the twelve months ending March 2007 according to IMS Health data.

Source:

http://www.actavis.com/

Posted in: Pharmaceutical News

Tags: ,

Comments (0)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback